Cart
sales@molnova.com
Pepinemab
CAS No. 2097151-87-4
Pepinemab( —— )
Catalog No. M36877 CAS No. 2097151-87-4
Pepinemab(VX 15/2503) is a humanized IgG4 monoclonal antibody targeting sematone 4D.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 301 | Get Quote |
|
| 5MG | 549 | Get Quote |
|
| 10MG | 882 | Get Quote |
|
| 25MG | 1270 | Get Quote |
|
| 50MG | 1711 | Get Quote |
|
| 100MG | 2241 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePepinemab
-
NoteResearch use only, not for human use.
-
Brief DescriptionPepinemab(VX 15/2503) is a humanized IgG4 monoclonal antibody targeting sematone 4D.
-
DescriptionPepinemab (VX 15/2503) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), also known as CD100, which is a regulator of neuronal development and plays a role in a variety of cellular processes. Pepinemab can be used in the study of various neurodegenerative diseases such as Alzheimer's disease by blocking the activity of SEMA4D.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2097151-87-4
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Elizabeth E Evans, et al. Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity. J Neuroinflammation. 2022 Aug 6;19(1):200.?
molnova catalog
related products
-
Tectoquinone
Tectoquinone exhibits strong mosquito larvicidal activity.Mosquito larvicidal activities of methanolic extracts from different plant parts of red heartwood-type Cryptomeria japonica D.
-
Saponin C, from Liri...
Saponin C from Liriope muscari can be extracted from Liriope muscari, family Liliaceae.
-
SMS2-IN-2
SMS2-IN-2 is a potent selective and orally active sphingomyelin synthase 2 (SMS2) inhibitor (IC50s of 100 and 56 μM for SMS2 and SMS1 respectively). SMS2-IN-2 has anti-chronic inflammatory activity.
